Coronavirus disease 2019(COVID-19),the disease caused by infection with se-vere acute respiratory syndrome coron-avirus 2(SARS-CoV-2),has developed into a global pandemic that continues to pose an enormous threat to public health and the global economy.Since the first SARS-CoV-2 genome was released[1],thousands of genetic variants have been identified in SARS-CoV-2 strains isolated from worldwide patients.Some variants in the spike(S)protein have been re-ported to be associated with functional changes in viral transmissibility or viral loads,such as the D614G variant[2,3],the N501Y change,the P681H substitu-tion and deletion of AH69-AV70[4].However,there is currently little direct evidence linking the genomic variants and clinical severity of COVID-19.